Off-Label Drug Use in Schizophrenia Treatment
Author Information
Author(s): David Pickar, Jessie Vinik, John J. Bartko
Primary Institution: Gabriel Sciences, LLC
Hypothesis
What are the patterns of off-label drug use in the treatment of schizophrenia in community settings?
Conclusion
The study found that 70% of patients with schizophrenia were treated with off-label medication combinations, primarily involving antipsychotics and mood stabilizers.
Supporting Evidence
- 70% of patients received an antipsychotic and another drug class.
- 42.5% of patients received more than one antipsychotic drug.
- 25.5% of patients received antipsychotic monotherapy.
Takeaway
Doctors often use medications for schizophrenia that aren't officially approved for that purpose, and many patients take more than one type of medicine to help them feel better.
Methodology
This cross-sectional study involved structured interviews and data collection from 200 community-based patients diagnosed with schizophrenia.
Potential Biases
Potential bias due to reliance on self-reported medication use and the lack of randomized controlled trials for off-label uses.
Limitations
The study may not represent all schizophrenia patients as it focused on those in community treatment settings.
Participant Demographics
{"mean_age":45.1,"gender_distribution":{"female":81,"male":119},"race_distribution":{"african_american":104,"caucasian":90,"asian":6},"marital_status":{"never_married":150,"married":18,"divorced_separated":22},"hospitalization_history":{"no":105,"yes":95},"suicide_attempt_history":{"no":104,"yes":96}}
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website